Broadly neutralizing antibodies target the coronavirus fusion peptide simplomarketing Broadly neutralizing antibodies target the coronavirus fusion peptide Read More »
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity Leave a Comment / simplomarketing A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity Read More »
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL Leave a Comment / simplomarketing Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL Read More »
Enabling Allogeneic T Cell-Based Therapies: Scalable Stirred-Tank Bioreactor Mediated Manufacturing Leave a Comment / simplomarketing Enabling Allogeneic T Cell-Based Therapies: Scalable Stirred-Tank Bioreactor Mediated Manufacturing Read More »
Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies Leave a Comment / simplomarketing Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies Read More »
Cytosine Base Editing Enables Quadruple-Edited Allogeneic CAR-T Cells for T-ALL Leave a Comment / simplomarketing Cytosine Base Editing Enables Quadruple-Edited Allogeneic CAR-T Cells for T-ALL Read More »
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models Leave a Comment / simplomarketing Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models Read More »
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk Leave a Comment / simplomarketing CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk Read More »
T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity Leave a Comment / simplomarketing T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity Read More »
Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system Leave a Comment / simplomarketing Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system Read More »
